1. Home
  2. HIT vs FLNA Comparison

HIT vs FLNA Comparison

Compare HIT & FLNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Health In Tech Inc.

HIT

Health In Tech Inc.

HOLD

Current Price

$0.86

Market Cap

74.1M

Sector

Finance

ML Signal

HOLD

FLNA

Filana Therapeutics Inc. Common Stock

N/A

Current Price

$0.74

Market Cap

61.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HIT
FLNA
Founded
1964
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
74.1M
61.8M
IPO Year
2024
2000

Fundamental Metrics

Financial Performance
Metric
HIT
FLNA
Price
$0.86
$0.74
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $3.25
N/A
AVG Volume (30 Days)
46.6K
★ 4.3M
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 100.00
N/A
EPS
★ N/A
N/A
Revenue
$33,327,511.00
★ $41,119,000.00
Revenue This Year
$41.00
N/A
Revenue Next Year
$69.63
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 70.99
N/A
52 Week Low
$0.77
$0.67
52 Week High
$4.01
$2.03

Technical Indicators

Market Signals
Indicator
HIT
FLNA
Relative Strength Index (RSI) 39.92 43.49
Support Level $0.77 $0.67
Resistance Level $1.16 $1.02
Average True Range (ATR) 0.07 0.09
MACD 0.00 0.01
Stochastic Oscillator 40.09 12.86

Price Performance

Historical Comparison
HIT
FLNA

About HIT Health In Tech Inc.

Health In Tech Inc is an AI-enabled insurance technology platform company that offers a marketplace that improves processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, it streamlines the underwriting, sales, and service process for insurance companies, licensed brokers, Managing General Underwriter (MGUs), and third-party administrators (TPAs). The company's platform serves as a marketplace for brokers, TPAs, MGUs and carriers with self-funded health insurance options for employers. The platform includes functions such as plan customization, stop-loss quoting, underwriting, claims administration, and reporting integration.

About FLNA Filana Therapeutics Inc. Common Stock

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Share on Social Networks: